The ever-changing challenges in the ICU can be demanding
At Baxter, we recognize the complexity of the challenges you face when caring for the most critically ill patients, after speaking with healthcare professionals around the world for more than 20+ years. Through this collaboration, we have identified three of your key challenges where we can best support you:
Operational efficiency
High workload during therapy setup and delivery
Diverse treatment needs
Patients requiring multi-organ support therapies
Complex clinical processes
Complicated therapy setup and delivery
Complicated therapy delivery
Simplify the complexities of CRRT and other extracorporeal therapies with the user-friendly interface of the PrisMax 2 system that helps enable seamless therapy management, from set-up to delivery.
Make documentation easier with TrueVue Connect, a digital add-on communication module, which help enable auto-documentation with enhanced EMR connectivity.
The need for multiple therapies can lead to complexities in therapy delivery
Deliver a range of therapies on the PrisMax 2 system without adding complexities in delivery: CRRT, blood purification for sepsis management to remove cytokines and endotoxins, ECCO₂R and TPE.
Deliver CRRT, ECCO₂R, and blood purification for sepsis management as stand-alone therapies or in combination with CRRT with a single vascular access1.
Delivering CRRT efficiently
Streamline clinical workflows and increase efficiency with the PrisMax 2 system’s intelligent features that can help reduce device interactions and decrease therapy downtime1.
Optimize your CRRT program by using data-driven insights enabled by TrueVue Therapy Management.
Accurate therapy delivery involves multiple factors
Increase accuracy of treatment delivery with the PrisMax 2 system.
The TherMax blood warmer allows effective blood warming for extracorporeal therapies while giving physicians precise control of return blood temperature1.
The Patient Fluid Removal (PFR) Catch-up helps clinicians meet prescribed fluid removal targets when treatment interruptions occur and helps deliver more accurate treatments compared to the Prismaflex system1.
Related Products
IMPORTANT SAFETY INFORMATION
The PrisMax control unit is intended for:
• Continuous Renal Replacement Therapy (CRRT) for patients with acute renal failure and/or fluid overload.
• Therapeutic Plasma Exchange (TPE) therapy for patients with diseases where removal of plasma components is indicated.
• Hemoperfusion (HP) for patients with conditions where immediate removal of substances by adsorption is indicated.
• Extracorporeal CO2 Removal (ECCO2R) for patients with conditions where extracorporeal elimination of carbon dioxide is indicated.
The Prismaflex control unit is intended for:
• Continuous Renal Replacement Therapy for patients with acute renal failure and/or fluid overload.
• Therapeutic Plasma Exchange Therapy for patients with diseases where removal of plasma components is indicated.
• Hemoperfusion for patients with conditions where immediate removal of substances by adsorption is indicated.
• Hemopurification for patients with conditions where extracorporeal elimination of carbon dioxide is indicated.
The PrismaLung+ device is indicated to provide extracorporeal CO₂ removal (ECCO₂R) as a stand-alone therapy or in combination with Continuous Renal Replacement Therapy (CRRT). It is intended for patients with increased levels of CO₂ in their blood and with a body weight greater than or equal to 30 kg (66 lb).
The TherMax blood warmer is intended for use in combination with the PrisMax control unit using Prismaflex filter sets for the warming of blood during extracorporeal blood circulation.
For safe and proper use of the products mentioned herein, please refer to the Operator’s Manual or Instructions for Use.
